1. What is the Chemxpert database?

Chemxpert database is a techno-commercial information platform developed and operated by Lifescience Intellipedia Pvt. Ltd. Our data provides valuable insights regarding sourcing, marketing, development, and regulatory functions for the entire Lifescience industry. The different industries covered by our data encompass APIs, FDFs, pharma intermediates, paints, dyes, polymers, biotechnology, biochemical, food additives, nutraceuticals, etc.

2. How can I subscribe to the Chemxpert database?

You can gain access to the Chemxpert database after subscribing to it by visiting this link: - https://chemxpert.com/pricing

3. How many countries' data is available on your portal?

The Chemxpert database covers more than 200 countries. We are working in the direction of expanding our data coverage in more countries.

4. What are the different sources you use for obtaining information?

The different sources we use for data collection are as follows: - • Primary researc • DMF, ANDA, & CEP list • Conferences, Exhibitions, & Tradeshow • Company annual reports • DMF, ANDA, & CEP list • Subject matter experts & KOL survey. Apart from these, our other valuable sources include application-wise manufacturers list, subscribed and non-subscribed databases, corporate partners, US FDA Orange book, publicly available sources, industry associates, national statistics, regulatory websites, etc. You can gain access to the Chemxpert database after subscribing to it by visiting this link: -https://chemxpert.com/sources

5. What is the expected time for account activation?

Your Chemxpert account will be activated instantly if the payment is made through our website. If you choose to use RTGS, NEFT, or IMPS systems for payment, your account will be activated within 24 hours.

16 May 2022
Admin
News Article

Zydus Lifesciences Launches Drug For Treating Bad Cholesterol

"With Bemdac We Are Happy To Introduce A First-In-India Therapy To Address The Unmet Medical Need Of People Suffering From Uncontrolled Ldl-C," Zydus Lifesciences Managing Director Sharvil Patel Said. Zydus Lifesciences On Friday Said It Has Launched In India Its Bempedoic Acid Drug Under The Bemdac Brand For Treatment Of Uncontrolled Levels Of Bad Cholesterol. Bemdac (Bempedoic Acid) Is A New Class Of Drug Which Is Orally Administered And Offers A New Line Of Treatment For Patients Suffering From Uncontrolled Levels Of Ldl-Cholesterol (Ldl-C) Despite Lifestyle Modifications And The Use Of Maximum Tolerated Dose Of Statins, Which Form The Cornerstone Of Dyslipidemia Management, The Company Said In A Regulatory Filing. "With Bemdac We Are Happy To Introduce A First-In-India Therapy To Address The Unmet Medical Need Of People Suffering From Uncontrolled Ldl-C," Zydus Lifesciences Managing Director Sharvil Patel Said Stating That Bemdac Is An Important Addition To Zydus' Portfolio Of Medicines For Managing Dyslipidemia And Cholesterol, Patel Said The Mission Is To Empower Patients With A Better Quality Of Life Through Effective Disease Management And With Bemdac The Company Has Taken A Great Leap Ahead In This Endeavour. The Company Said Ldl-C Is Often Referred To As Bad Cholesterol Since It Gets Deposited In The Walls Of The Blood Vessels, Increasing The Chances Of Health Problems Like Heart Attack Or Stroke. Uncontrolled Ldl-C Is A Major Risk Factor For Developing Cardiovascular Diseases. Citing Various Studies, Zydus Said, 8 Out Of 10 Indians Are Dyslipidemic1 And 112 Million Adults Suffer From High Levels Of Ldl-C; 7 Out Of 10 Dyslipidemia Patients Who Are On Statin Treatment Continue To Suffer From Uncontrolled Ldl-C. Besides This, 5.4 Million Indians Are Found To Be Intolerant To Statin Therapy, It Added. Bempedoic Acid Has Also Shown To Have Good Results In Patients Not Able To Tolerate Statins And Those Who Do Not Respond To Statins. This Is A Huge Unmet Healthcare Need Which Bemdac Addresses, Zydus Claimed

Let’s apply Data-Driven Pricing to Your APIs

Sick and tired of always wondering if you are being asked to pay the right price for your APIs? This empowers you with the answers you need to make the right decisions in the Global API market.

Chemxpert Database is one of the biggest and most comprehensive directories of pharma and chemicals, manufacturers, suppliers and information. Provided with current information on prices, demand and transactions, it gives you instant feedback on whether you are buying what is right and at the right time.

Start using market intelligence today and allow yourself to be in control in the API market.

Check it out today and make more informed sourcing decisions! Learn More!